Good afternoon :)
Place Order
Add to Watchlist

Parabolic Drugs Ltd

PARABDRUGS Share Price

% (-)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹34 cr, stock is ranked 3,892

Stock is 0.00x as volatile as Nifty

PARABDRUGS Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Low

Profitability and efficiency haven't been upto the mark

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

With a market cap of ₹34 cr, stock is ranked 3,892

Stock is 0.00x as volatile as Nifty

PARABDRUGS Performance & Key Metrics

PARABDRUGS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-0.04
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.596.400.79%

PARABDRUGS Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

PARABDRUGS Company Profile

Parabolic Drugs Limited is an integrated, research-based, pharmaceutical manufacturer and exporter, engaged in development and manufacturing of Active Pharmaceutical Ingredients (API) and API intermediates.

PARABDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers 

PARABDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
36.50
36.50
1Y Return
5.71%
5.71%
Buy Reco %
87.10
87.10
PE Ratio
22.64
22.64
1Y Return
1.39%
1.39%
Buy Reco %
73.33
73.33
PE Ratio
59.13
59.13
1Y Return
12.03%
12.03%
Buy Reco %
70.83
70.83
PE Ratio
18.58
18.58
1Y Return
4.87%
4.87%
Buy Reco %
51.72
51.72
PE Ratio
52.73
52.73
1Y Return
21.78%
21.78%
Buy Reco %
81.25
81.25
Compare with Peers

PARABDRUGS Forecast

PARABDRUGS Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

PARABDRUGS

PARABDRUGS

Income

Balance Sheet

Cash Flow

PARABDRUGS Income Statement

PARABDRUGS Income Statement

Loading...

Financial YearFY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020TTM
Total Revenue928.42772.88450.63233.3877.1681.1077.3218.890.02
Raw Materialssubtract800.45691.04391.42209.0259.0764.8764.6034.726.41
Power & Fuel Costsubtract9.8110.0217.2215.2610.178.976.87
Employee Costsubtract22.5223.7519.2317.4610.919.039.83
Selling & Administrative Expensessubtract23.3125.5520.6914.068.696.075.77
Operating & Other expensessubtract-89.0994.7572.2055.52294.7432.582.20
Depreciation/Amortizationsubtract30.8555.1968.2573.2067.2253.6534.5422.5221.59
Interest & Other Itemssubtract64.1473.2483.7098.99107.6210.979.303.460.66
Taxes & Other Itemssubtract15.23-56.17-88.28130.324.433.051.76-0.410.00
EPS8.27-23.35-21.62-61.47-78.47-17.46-9.30-6.57-4.63
DPS0.250.000.000.000.000.000.000.00
Payout ratio0.030.000.000.000.000.000.000.000.00

PARABDRUGS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
FY 2014FY 2014

Annual report

PDF
FY 2013FY 2013

Annual report

PDF
FY 2012FY 2012

Annual report

PDF
 

PARABDRUGS Stock Peers

PARABDRUGS Past Performance & Peer Comparison

PARABDRUGS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Parabolic Drugs Ltd-1.19-0.04
Sun Pharmaceutical Industries Ltd36.505.500.96%
Cipla Ltd22.643.821.08%
Torrent Pharmaceuticals Ltd59.1314.890.18%

PARABDRUGS Stock Price Comparison

Compare PARABDRUGS with any stock or ETF
Compare PARABDRUGS with any stock or ETF
PARABDRUGS
Loading...

PARABDRUGS Holdings

PARABDRUGS Shareholdings

PARABDRUGS Promoter Holdings Trend

PARABDRUGS Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

PARABDRUGS Institutional Holdings Trend

PARABDRUGS Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

PARABDRUGS Shareholding Pattern

PARABDRUGS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding37.79%0.00%0.57%8.06%53.57%

Mar 2020

Jun 2020

Sep 2020

Dec 2020

PARABDRUGS Shareholding History

PARABDRUGS Shareholding History

SepDec '19MarJunSepDec '208.06%8.06%8.06%8.06%8.06%8.06%

PARABDRUGS Insider Trades & Bulk Stock Deals

PARABDRUGS Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing PARABDRUGS stock

smallcases containing PARABDRUGS stock

Looks like this stock is not in any smallcase yet.

PARABDRUGS Events

PARABDRUGS Events

PARABDRUGS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

PARABDRUGS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

PARABDRUGS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

PARABDRUGS has not given any dividends in last 5 years

PARABDRUGS Upcoming Dividends

PARABDRUGS Upcoming Dividends

No upcoming dividends are available

PARABDRUGS Past Dividends

PARABDRUGS Past Dividends

Cash Dividend

Ex DateEx DateSep 24, 2012

Final
Final | Div/Share: ₹0.25

Dividend/Share

0.25

Ex DateEx Date

Sep 24, 2012

Cash Dividend

Ex DateEx DateSep 19, 2011

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 19, 2011